ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 896 filers reported holding ASTRAZENECA PLC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $658,035 | -5.4% | 9,717 | 0.0% | 0.06% | 0.0% |
| Q2 2023 | $695,446 | +3.1% | 9,717 | 0.0% | 0.06% | -26.7% |
| Q1 2023 | $674,457 | -0.7% | 9,717 | -3.0% | 0.08% | -3.8% |
| Q4 2022 | $679,153 | +23.7% | 10,017 | 0.0% | 0.08% | +14.7% |
| Q3 2022 | $549,000 | -17.1% | 10,017 | 0.0% | 0.07% | -12.8% |
| Q2 2022 | $662,000 | -0.5% | 10,017 | 0.0% | 0.08% | +18.2% |
| Q1 2022 | $665,000 | +14.1% | 10,017 | 0.0% | 0.07% | +22.2% |
| Q4 2021 | $583,000 | -3.2% | 10,017 | 0.0% | 0.05% | -5.3% |
| Q3 2021 | $602,000 | +1.2% | 10,017 | +0.8% | 0.06% | 0.0% |
| Q2 2021 | $595,000 | +9.4% | 9,937 | -9.1% | 0.06% | +3.6% |
| Q1 2021 | $544,000 | -0.5% | 10,937 | 0.0% | 0.06% | -6.8% |
| Q4 2020 | $547,000 | -9.1% | 10,937 | +0.9% | 0.06% | -18.1% |
| Q3 2020 | $602,000 | +12.5% | 10,837 | +9.1% | 0.07% | +4.3% |
| Q2 2020 | $535,000 | +4.7% | 9,937 | -2.6% | 0.07% | -9.2% |
| Q1 2020 | $511,000 | +2.6% | 10,202 | +2.7% | 0.08% | +31.0% |
| Q4 2019 | $498,000 | +16.1% | 9,937 | 0.0% | 0.06% | +3.6% |
| Q3 2019 | $429,000 | +4.6% | 9,937 | 0.0% | 0.06% | +7.7% |
| Q2 2019 | $410,000 | +1.2% | 9,937 | -0.8% | 0.05% | -1.9% |
| Q1 2019 | $405,000 | +6.6% | 10,017 | 0.0% | 0.05% | -5.4% |
| Q4 2018 | $380,000 | -4.0% | 10,017 | 0.0% | 0.06% | +16.7% |
| Q3 2018 | $396,000 | +13.5% | 10,017 | +0.8% | 0.05% | +6.7% |
| Q2 2018 | $349,000 | +0.6% | 9,937 | 0.0% | 0.04% | -2.2% |
| Q1 2018 | $347,000 | +0.6% | 9,937 | 0.0% | 0.05% | +4.5% |
| Q4 2017 | $345,000 | +2.4% | 9,937 | 0.0% | 0.04% | -6.4% |
| Q3 2017 | $337,000 | +12.0% | 9,937 | +12.6% | 0.05% | -9.6% |
| Q2 2017 | $301,000 | +9.5% | 8,824 | 0.0% | 0.05% | +8.3% |
| Q1 2017 | $275,000 | +14.1% | 8,824 | 0.0% | 0.05% | +4.3% |
| Q4 2016 | $241,000 | -32.9% | 8,824 | -19.2% | 0.05% | -35.2% |
| Q3 2016 | $359,000 | +8.8% | 10,924 | 0.0% | 0.07% | +7.6% |
| Q2 2016 | $330,000 | +6.1% | 10,924 | -1.0% | 0.07% | +1.5% |
| Q1 2016 | $311,000 | -1.3% | 11,039 | +19.1% | 0.06% | -4.4% |
| Q4 2015 | $315,000 | +29.6% | 9,270 | +21.2% | 0.07% | +25.9% |
| Q3 2015 | $243,000 | -1.6% | 7,647 | +97.0% | 0.05% | +8.0% |
| Q2 2015 | $247,000 | -8.9% | 3,881 | -2.1% | 0.05% | -7.4% |
| Q1 2015 | $271,000 | -2.9% | 3,966 | 0.0% | 0.05% | -3.6% |
| Q4 2014 | $279,000 | -1.4% | 3,966 | 0.0% | 0.06% | -1.8% |
| Q3 2014 | $283,000 | -7.2% | 3,966 | -3.3% | 0.06% | -5.0% |
| Q2 2014 | $305,000 | +13.8% | 4,101 | -0.8% | 0.06% | +9.1% |
| Q1 2014 | $268,000 | +20.2% | 4,136 | +10.1% | 0.06% | +14.6% |
| Q4 2013 | $223,000 | +9.9% | 3,756 | -3.8% | 0.05% | +2.1% |
| Q3 2013 | $203,000 | – | 3,906 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |